BlackRock Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.92M | Sell |
59,673
-94
| -0.2% | -$3.02K | ﹤0.01% | 2239 |
|
|
2016
Q3 | $2.99M | Sell |
59,767
-187
| -0.3% | -$9.34K | ﹤0.01% | 1858 |
|
|
2016
Q2 | $2.54M | Buy |
59,954
+8,922
| +17% | +$378K | ﹤0.01% | 1921 |
|
|
2016
Q1 | $3.36M | Buy |
51,032
+2,901
| +6% | +$191K | ﹤0.01% | 1642 |
|
|
2015
Q4 | $2.99M | Buy |
48,131
+897
| +2% | +$55.8K | ﹤0.01% | 1785 |
|
|
2015
Q3 | $3.16M | Sell |
47,234
-524
| -1% | -$35.1K | ﹤0.01% | 1706 |
|
|
2015
Q2 | $4.65M | Buy |
47,758
+12,956
| +37% | +$1.26M | 0.01% | 1558 |
|
|
2015
Q1 | $3.25M | Buy |
34,802
+564
| +2% | +$52.7K | ﹤0.01% | 1690 |
|
|
2014
Q4 | $3.04M | Sell |
34,238
-304
| -0.9% | -$27K | ﹤0.01% | 1723 |
|
|
2014
Q3 | $2.39M | Buy |
34,542
+46
| +0.1% | +$3.18K | ﹤0.01% | 1862 |
|
|
2014
Q2 | $1.98M | Buy |
34,496
+401
| +1% | +$23K | ﹤0.01% | 2066 |
|
|
2014
Q1 | $1.35M | Buy |
34,095
+131
| +0.4% | +$5.2K | ﹤0.01% | 2278 |
|
|
2013
Q4 | $1.43M | Sell |
33,964
-607
| -2% | -$25.5K | ﹤0.01% | 2242 |
|
|
2013
Q3 | $1.03M | Buy |
34,571
+4,546
| +15% | +$136K | ﹤0.01% | 2406 |
|
|
2013
Q2 | $1.59M | Buy |
+30,025
| New | +$1.59M | ﹤0.01% | 2023 |
|